S

Sands Capital Ventures portfolio

Sands Capital Ventures has 4 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is K2 Space's $500M Series B+ round in July 2026, alongside T. Rowe Price, Spark Capital, Lightspeed and 5 others. By category, its portfolio leans toward Consumer and social (2) and Robotics and hardware (1). It has co-invested with T. Rowe Price, Ribbit Capital and Dragoneer, most often T. Rowe Price (2 rounds).

What Sands Capital Ventures invests in

• Consumer and social · 2 · 50%
• Robotics and hardware · 1 · 25%
• Manufacturing and industrial · 1 · 25%
• Lending and credit · 1 · 25%
• Fintech · 1 · 25%
• Health and bio · 1 · 25%
• Data and analytics · 1 · 25%
• HR and recruiting · 1 · 25%

Sands Capital Ventures recent investments

Company	Round	Date	Alongside
KK2 Space	Series B+ · $500M	Jul 30, 2026	T. Rowe Price, Spark Capital, Lightspeed +5
UUpgrade	Series B+ · $280M	Nov 16, 2021	Vy Capital, Ventura Capital, Ribbit Capital +6
PPersonal Genome Diagnostics	Series B+ · $100M	Feb 1, 2021	Windham Venture Partners, Vensana Capital, Rock Springs Capital +6
SSlack	Series B+ · $430M	Aug 1, 2018	Wellington Management, T. Rowe Price, SoftBank Vision Fund +4
UUpgrade	Series A · $60M	Mar 1, 2017	Vy Capital, Uprising Ventures, Union Square Ventures +6

How Sands Capital Ventures invests

Share is of the 5 rounds on Recent Funding that name Sands Capital Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Sands Capital Ventures portfolio companies

• KK2 Space$500MSeries B+ · Jul 2026
• UUpgrade$280MSeries B+ · Nov 2021
• PPersonal Genome Diagnostics$100MSeries B+ · Feb 2021
• SSlack$430MSeries B+ · Aug 2018

Company	Round with Sands Capital Ventures	Total raised	Latest raise
KK2 Space Robotics and hardware	Jul 30, 2026 Series B+ · $500M	$917M	Jul 30, 2026 Series B+
UUpgrade Lending and credit	Nov 16, 2021 Series B+ · $280M	$650M	Oct 20, 2025 Series B+
PPersonal Genome Diagnostics Health and bio	Feb 1, 2021 Series B+ · $100M	$123.8M	Nov 24, 2025 Series B+
SSlack HR and recruiting	Aug 1, 2018 Series B+ · $430M	$435M	Nov 9, 2023 Seed

Most frequent co-investors

• TT. Rowe Price2 shared rounds · last Jul 30, 2026
• RRibbit Capital2 shared rounds · last Nov 16, 2021
• DDragoneer2 shared rounds · last Nov 16, 2021
• VVy Capital2 shared rounds · last Nov 16, 2021
• LLightspeed1 shared round · last Jul 30, 2026
• AAltimeter Capital1 shared round · last Jul 30, 2026
• SSpark Capital1 shared round · last Jul 30, 2026
• KKleiner Perkins1 shared round · last Jul 30, 2026
• IICONIQ1 shared round · last Jul 30, 2026
• CCapitalG1 shared round · last Jul 30, 2026
• AARK Investment Management1 shared round · last Jul 30, 2026
• GG Squared1 shared round · last Nov 16, 2021

Similar investors

• VVanEck4 companies · 3 deals in 12 mo
• EEQT Growth4 companies · 2 deals in 12 mo
• WWicklow Capital4 companies · 2 deals in 12 mo
• BbyFounders4 companies · 1 deal in 12 mo
• DDST4 companies · 1 deal in 12 mo
• GGenesia Ventures4 companies · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Consumer and social).

Portfolio companies are the companies on Recent Funding with a round that lists Sands Capital Ventures, which is a subset of its real portfolio. API: /api/v1/investors/sands-capital-ventures (get a free API key). More: the most active VC firms and new venture capital funds.